Ozamore DS Cream contains Ozenoxacin 2% w/w, a non-fluorinated quinolone antibiotic indicated for the topical treatment of impetigo and other superficial bacterial skin infections caused by susceptible strains of Staphylococcus aureus and Streptococcus pyogenes. Ozenoxacin exhibits potent bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair. The cream formulation allows for effective local delivery, minimizing systemic absorption and associated adverse effects. Ozamore DS Cream is applied topically to the affected area twice daily, typically for a duration of 5 days or as directed by a healthcare professional. It is well tolerated, with minimal risk of irritation or sensitization. Due to its broad-spectrum activity and low potential for resistance development, Ozamore DS Cream is a valuable option in managing uncomplicated superficial skin infections. Caution is advised in patients with known hypersensitivity to quinolones or any component of the formulation. The product should not be used on open wounds or mucous membranes. Proper hygiene and adherence to the prescribed treatment regimen enhance therapeutic outcomes and reduce the risk of bacterial resistance. Consult a healthcare provider if symptoms persist or worsen during therapy.